Lisa K. Woolhiser

1.2k total citations
18 papers, 634 citations indexed

About

Lisa K. Woolhiser is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Lisa K. Woolhiser has authored 18 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Lisa K. Woolhiser's work include Tuberculosis Research and Epidemiology (16 papers), Cancer therapeutics and mechanisms (9 papers) and Mycobacterium research and diagnosis (6 papers). Lisa K. Woolhiser is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Cancer therapeutics and mechanisms (9 papers) and Mycobacterium research and diagnosis (6 papers). Lisa K. Woolhiser collaborates with scholars based in United States, France and Uganda. Lisa K. Woolhiser's co-authors include Anne J. Lenaerts, Veronica Gruppo, Ian M. Orme, Mary Ann De Groote, Elizabeth J. Brooks, Robert C. Reynolds, Randall J. Basaraba, Iona L. Bartek, Courtney Hastings and William R. Jacobs and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Lisa K. Woolhiser

16 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa K. Woolhiser United States 15 363 255 230 127 93 18 634
Suresh B. Lakshminarayana Singapore 12 333 0.9× 196 0.8× 216 0.9× 110 0.9× 55 0.6× 15 573
Katherine A. Abrahams United Kingdom 12 393 1.1× 410 1.6× 233 1.0× 113 0.9× 66 0.7× 17 629
Jiuyu Liu United States 14 323 0.9× 388 1.5× 166 0.7× 170 1.3× 50 0.5× 42 736
Thulasi Warrier United States 15 335 0.9× 284 1.1× 257 1.1× 137 1.1× 35 0.4× 24 647
David Barros Spain 19 478 1.3× 458 1.8× 260 1.1× 198 1.6× 112 1.2× 22 870
Steven M. Denkin United States 12 347 1.0× 306 1.2× 240 1.0× 86 0.7× 25 0.3× 14 685
Giulia Degiacomi Italy 15 517 1.4× 426 1.7× 386 1.7× 151 1.2× 46 0.5× 35 829
Romain Veyron‐Churlet France 15 543 1.5× 420 1.6× 478 2.1× 91 0.7× 36 0.4× 24 840
Jorge Ramos Portugal 13 517 1.4× 376 1.5× 444 1.9× 132 1.0× 37 0.4× 26 901
Tamara Hess United States 7 364 1.0× 273 1.1× 273 1.2× 122 1.0× 37 0.4× 7 567

Countries citing papers authored by Lisa K. Woolhiser

Since Specialization
Citations

This map shows the geographic impact of Lisa K. Woolhiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa K. Woolhiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa K. Woolhiser more than expected).

Fields of papers citing papers by Lisa K. Woolhiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa K. Woolhiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa K. Woolhiser. The network helps show where Lisa K. Woolhiser may publish in the future.

Co-authorship network of co-authors of Lisa K. Woolhiser

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa K. Woolhiser. A scholar is included among the top collaborators of Lisa K. Woolhiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa K. Woolhiser. Lisa K. Woolhiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cummings, Jason E., Lisa K. Woolhiser, Adele Romano, et al.. (2025). Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatment. Frontiers in Pharmacology. 16. 1667592–1667592.
2.
Cummings, Jason E., Lisa K. Woolhiser, Barbara Graham, et al.. (2025). Establishing translational performance standards for TB therapy using rifampicin-based regimens in a male and female high-burden murine model. BMC Microbiology. 25(1). 462–462.
3.
Robertson, Gregory T., Lisa M. Massoudi, Claire L. Carter, et al.. (2021). Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832. Antimicrobial Agents and Chemotherapy. 65(11). e0058321–e0058321. 44 indexed citations
4.
Moraski, Garrett C., Nathalie Deboosère, Kate Marshall, et al.. (2020). Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. PLoS ONE. 15(1). e0227224–e0227224. 33 indexed citations
5.
Lu, Xiaoyun, Kiel Hards, Chen‐Yi Cheung, et al.. (2018). Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis. ACS Infectious Diseases. 5(2). 239–249. 69 indexed citations
6.
Rakesh, Rakesh, David F. Bruhn, Michaël Scherman, et al.. (2014). Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis. PLoS ONE. 9(2). e87909–e87909. 29 indexed citations
7.
Bartek, Iona L., Lisa K. Woolhiser, Anthony D. Baughn, et al.. (2014). Mycobacterium tuberculosis Lsr2 Is a Global Transcriptional Regulator Required for Adaptation to Changing Oxygen Levels and Virulence. mBio. 5(3). e01106–14. 65 indexed citations
8.
Ekins, Sean, Robert C. Reynolds, Hiyun Kim, et al.. (2013). Bayesian Models Leveraging Bioactivity and Cytotoxicity Information for Drug Discovery. Chemistry & Biology. 20(3). 370–378. 81 indexed citations
9.
Fávaro, Wagner José, et al.. (2012). Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer. Infectious Agents and Cancer. 7(1). 14–14. 44 indexed citations
10.
Gonzalez‐Juarrero, Mercedes, Lisa K. Woolhiser, Elizabeth J. Brooks, Mary Ann DeGroote, & Anne J. Lenaerts. (2012). Mouse Model for Efficacy Testing of Antituberculosis Agents via Intrapulmonary Delivery. Antimicrobial Agents and Chemotherapy. 56(7). 3957–3959. 22 indexed citations
11.
Mathew, Bini, Shefali Srivastava, Larry J. Ross, et al.. (2011). Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors. Bioorganic & Medicinal Chemistry. 19(23). 7120–7128. 40 indexed citations
12.
Groote, Mary Ann De, et al.. (2011). Importance of Confirming Data on the In Vivo Efficacy of Novel Antibacterial Drug Regimens against Various Strains of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 56(2). 731–738. 31 indexed citations
13.
Mahapatra, Sebabrata, Lisa K. Woolhiser, Anne J. Lenaerts, et al.. (2011). A Novel Metabolite of Antituberculosis Therapy Demonstrates Host Activation of Isoniazid and Formation of the Isoniazid-NAD+Adduct. Antimicrobial Agents and Chemotherapy. 56(1). 28–35. 42 indexed citations
14.
Groote, Mary Ann De, Elizabeth J. Brooks, Lisa K. Woolhiser, et al.. (2010). Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 55(3). 1237–1247. 70 indexed citations
15.
Sun, Dianqing, Michaël Scherman, Victoria Jones, et al.. (2009). Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity. Bioorganic & Medicinal Chemistry. 17(10). 3588–3594. 20 indexed citations
16.
Lenaerts, Anne J., et al.. (2008). Evaluation of a 2-Pyridone, KRQ-10018, against Mycobacterium tuberculosis In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 52(4). 1513–1515. 21 indexed citations
17.
Woolhiser, Lisa K., et al.. (2008). Testing of Experimental Compounds in a Relapse Model of Tuberculosis Using Granulocyte-Macrophage Colony-Stimulating Factor Gene-Disrupted Mice. Antimicrobial Agents and Chemotherapy. 53(1). 306–308. 6 indexed citations
18.
Woolhiser, Lisa K., Baolin Wang, Veronica Gruppo, et al.. (2007). In Vivo Adaptation of the Wayne Model of Latent Tuberculosis. Infection and Immunity. 75(5). 2621–2625. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suresh B. Lakshminarayana Breakdown of academic impact, for papers by Katherine A. Abrahams Breakdown of academic impact, for papers by Jiuyu Liu Breakdown of academic impact, for papers by Thulasi Warrier Breakdown of academic impact, for papers by David Barros Breakdown of academic impact, for papers by Steven M. Denkin Breakdown of academic impact, for papers by Giulia Degiacomi Breakdown of academic impact, for papers by Romain Veyron‐Churlet Breakdown of academic impact, for papers by Jorge Ramos Breakdown of academic impact, for papers by Tamara Hess
Rankless by CCL
2026